Table of Contents
1 Introducing the Field of Drug Delivery
- 1.1 The Value of Drug Delivery Systems
- 1.2 Drug Delivery and Product Differentiation
- 1.3 Drug Delivery and Patent Extension
- 1.4 The Optimal Time for Reformulation
- 1.5 Optimizing R&D Returns Through Drug Delivery
- 1.6 Opportunities and Threats to the Drug Delivery Sector
- 1.6.1 Opportunities for Growth in the Drug Delivery Sector
- 1.6.2 Threats to Additional Growth in the Drug Delivery Sector
- 1.7 Business Models of Drug Delivery Companies
2 An Overview of Drug Delivery Technologies
- 2.1 Oral Drug Delivery
- 2.1.1 Controlled Release
- 2.1.2 Sustained Release
- 2.1.3 Chronomodulation
- 2.1.4 Rapid Dissolving and Taste-masking Tablets
- 2.1.5 Macromolecular Drug Delivery
- 2.2 Inhalable Drug Delivery
- 2.2.1 Nebulizers
- 2.2.2 Metered Dose Inhalers (MDIs)
- 2.2.3 Dry Powder Inhalers (DPIs)
- 2.2.4 Limitations of Pulmonary Delivery Systems for Systemic Delivery
- 2.2.5 Aqueous Systems
- 2.3 Injectable Drug Delivery
- 2.3.1 Sustained Release Injectable Systems
- 2.3.2 Liposomal Systems
- 2.3.3 Needleless Systems
- 2.4 Transmucosal Drug Delivery
- 2.4.1 Buccal Delivery
- 2.4.2 Nasal
- 2.4.3 Rectal
- 2.4.4 Vaginal
- 2.5 Transdermal Drug Delivery
- 2.5.1 Passive Formulations
- 2.5.2 Active Formulations
- 2.6 Niche Technologies
- 2.6.1 Topical Systems
- 2.6.2 Gene Delivery
- 2.6.3 Implantable Systems
- 2.6.4 Drug Delivery Microchips
- 2.6.5 Nanotechnology
3 Drug Delivery Market Analysis
- 3.1 Key Market Segments
- 3.1.1 Oral Drug Delivery
- 3.1.1.1 Sales of Products Utilizing Oral Drug Delivery Technology
- 3.1.1.2 Key Therapeutic Areas for Oral Drug Delivery
- 3.1.1.3 Key Oral Drug Delivery Products Impacting Global Market
- 3.1.1.4 The Outlook for Oral Drug Delivery Technology
- 3.1.2 Inhalable Drug Delivery
- 3.1.2.1 Sales of Products Utilizing Inhalable Drug Delivery
- 3.1.2.2 Key Therapeutic Areas for Inhalable Drug Delivery
- 3.1.2.3 Key Inhalable Drug Delivery Products Impacting Global Market
- 3.1.2.4 The Outlook for Inhalable Drug Delivery Technology
- 3.1.3 Injectable Drug Delivery
- 3.1.3.1 Sales of Products Utilizing Injectable Drug Delivery Technology
- 3.1.3.2 Key Therapeutic Areas for Injectable Drug Delivery
- 3.1.3.3 Key Injectable Drug Delivery Products Impacting Global Market
- 3.1.3.4 The Outlook for Injectable Drug Delivery Technology
- 3.1.4 Transmucosal Drug Delivery
- 3.1.4.1 Sales of Products Utilizing Transmucosal Drug Delivery
Technology
- 3.1.4.2 Key Therapeutic Areas for Transmucosal Delivery
- 3.1.4.3 Key Transmucosal Drug Delivery Products Impacting Global Market
- 3.1.4.4 The Outlook for Transmucosal Drug Delivery Technology
- 3.1.5 Transdermal Drug Delivery
- 3.1.5.1 Sales of Products Utilizing Transdermal Drug Delivery
Technology
- 3.1.5.2 Key Therapeutic Areas for Transdermal Drug Delivery
- 3.1.5.3 Key Transdermal Drug Delivery Products Impacting Global Market
- 3.1.5.4 The Outlook for Transdermal Drug Delivery Technology
- 3.1.6 Niche Drug Delivery Technologies
- 3.1.6.1 Sales of Products Utilizing Niche Drug Delivery Technologies
- 3.1.6.2 Key Niche Drug Delivery Technology Product Impacting Global
Market
- 3.1.6.3 The Outlook for Niche Drug Delivery Technologies
4 Emerging Drug Delivery Technologies: Oral Drug Delivery
- 4.1 Key Product Profiles
- 4.2 Key Company Involvement in the Field of Oral Drug Delivery
- 4.2.1 ALZA
- 4.2.2 Biovail
- 4.2.3 Cardinal Health
- 4.2.4 Depomed
- 4.2.5 Emisphere
- 4.2.6 Ethypharm
- 4.2.7 Penwest
5 Emerging Drug Delivery Technologies: Inhalable Drug Delivery
- 5.1 Key Product Profiles
- 5.2 Key Company Involvement in the Field of Inhalable Drug Delivery
- 5.2.1 3M
- 5.2.2 Alkermes
- 5.2.3 Aradigm
- 5.2.4 Nektar
- 5.2.5 SkyePharma
6 Emerging Drug Delivery Technologies: Injectable Drug Delivery
- 6.1 Key Product Profiles
- 6.2 Key Company Involvement in the Field of Injectable Drug Delivery
- 6.2.1 Alkermes
- 6.2.2 ALZA
- 6.2.3 Aradigm
- 6.2.4 Enzon
- 6.2.5 Ethypharm
- 6.2.6 Macromed
- 6.2.7 Nektar
- 6.2.8 QLT
- 6.2.9 SkyePharma
7 Emerging Drug Delivery Technologies: Transmucosal Drug Delivery
- 7.1 Key Company Involvement in the Field of Transmucosal Drug Delivery
- 7.1.1 Generex
- 7.1.2 Nastech
- 7.1.3 Pherin
8 Emerging Drug Delivery Technologies: Transdermal Drug Delivery
- 8.1 Key Product Profiles
- 8.2 Key Company Involvement in the Field of Transdermal Drug Delivery
- 8.2.1 3M
- 8.2.2 Altea Therapeutics
- 8.2.3 ALZA
- 8.2.4 Noven
9 Emerging Drug Delivery Technologies: Niche Drug Delivery Technologies
- 9.1 Key Product Profiles
- 9.2 Key Company Involvement in Niche Drug Delivery Technologies
- 9.2.1 ALZA
- 9.2.2 Connetics
- 9.2.3 Inovio
- 9.2.4 MacroChem
- 9.2.5 NexMed
- 9.2.6 pSivida
- 9.2.7 QLT
- 9.2.8 SkyePharma
10 Key Drug Delivery Company Profiles
- 10.1 3M
- 10.2 Alkermes
- 10.3 Altea Therapeutics
- 10.4 ALZA (Johnson & Johnson)
- 10.5 Aradigm
- 10.6 Bioject
- 10.7 Biovail
- 10.8 Cardinal Health
- 10.9 Cima Labs (Cephalon)
- 10.10 Connetics
- 10.11 CyDex
- 10.12 Delsite Biotechnologies (Carrington Laboratories)
- 10.13 Depomed
- 10.14 DOR BioPharma
- 10.15 DURECT
- 10.16 Emisphere
- 10.17 Enzon
- 10.18 Ethypharm
- 10.19 Generex
- 10.20 Inovio (formerly Genetronics)
- 10.21 IVAX
- 10.22 MacroChem
- 10.23 MacroMed
- 10.24 Nastech
- 10.25 Nektar
- 10.26 NexMed
- 10.27 Noven
- 10.28 Penwest
- 10.29 Pherin Pharmaceuticals
- 10.30 QLT
- 10.31 SkyePharma
- 10.32 Watson Pharmaceuticals
11 Leading Pharmaceutical Companies Utilizing Drug Delivery Technologies
- 11.1 Pfizer
- 11.2 GlaxoSmithKline
- 11.3 Sanofi-Aventis
- 11.4 Merck
- 11.5 Johnson & Johnson
- 11.6 AstraZeneca
- 11.7 Novartis
- 11.8 Bristol-Myers Squibb
- 11.9 Wyeth
- 11.10 Abbott Labs
| 
View Cart
